搜索
 > 【IL-15】重组蛋白信息

IL-15信息

英文名称:Interleukin-15
中文名称:白细胞介素-15
靶点别称:Interleukin-15,IL15,IL-15
上市药物数量:0
临床药物数量:3
最高研发阶段:临床二期

IL-15产品列表

货号 物种 产品描述 蛋白结构 纯度 活性
IL5-H4117
Human
Human IL-15 Protein, Tag Free
IL5-M82F3
Mouse
Biotinylated Mouse IL-15 Protein, Fc Tag, Avi Tag
IL5-H82F3
Human
Biotinylated Human IL-15 Protein, Fc Tag, Avi Tag

IL-15 分子别名

IL-15,Interleukin-15,MGC9721

IL-15 分子背景

Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

IL-15 参考文献

IL-15临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
SHR-1501 SHR-1501,SHR1501 临床一期 江苏恒瑞 实体瘤
Anti-interleukin-15-vaccine-CIGB CIGB-50 临床一期 Center for Genetic Engineering and Biotechnology, Heber Biotech 类风湿性关节炎
AMG-714 AMG-714; HuMab-IL15 临床二期 Genmab, 安进, Celimmune 乳糜泻 详情

消息提示

请输入您的联系方式,再点击提交!

确定